Effects of an olmesartan medoxomil/amlodipine versus olmesartan medoxomil and amlodipine monotherapies in hypertensive patients

Trial Profile

Effects of an olmesartan medoxomil/amlodipine versus olmesartan medoxomil and amlodipine monotherapies in hypertensive patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jun 2015

At a glance

  • Drugs Olmesartan medoxomil/amlodipine (Primary) ; Amlodipine; Olmesartan medoxomil
  • Indications Essential hypertension
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 15 Jun 2015 Sub group analysis (in Hypertensive, Type 2 Diabetics patients) results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
    • 17 Jun 2013 Results presented at the 23rd European Meeting on Hypertension.
    • 11 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top